Clinical Trial Detail

NCT ID NCT02987959
Title Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Fox Chase Cancer Center
Indications

sarcoma

extraosseous osteosarcoma

leiomyosarcoma

fibrous histiocytoma

pleomorphic rhabdomyosarcoma

malignant peripheral nerve sheath tumor

pleomorphic liposarcoma

angiosarcoma

Therapies

Sapanisertib

Age Groups: senior adult

Additional content available in CKB BOOST